SOM Biotech collaborated in the organization of the University of Barcelona Summer Course: “Rare Diseases: from the patient to the cure”. Within the framework of the course, Dr. Raúl Insa, SOM Biotech CEO, did a master class included in the module “Pharmaceuticals in rare diseases”. The topic of his speech was: “Repositioning of drugs in rare diseases”.

This course was supported together with Pfizer (www.pfizer.es) and Duchenne Parent Project Spain (www.duchenne-spain.org).
The course addressed the development process that follows an orphan drug globally since it is identified until an orphan medicinal product is available for patients.

More information at http://www.juliols.ub.edu/curs-estiu/malalties-rares-pacient-cura.

       

SUBCRIBE TO OUR NEWSLETTER

    Name*
    Email*


    I confirm that by completing this form I have used only personal data about myself and that they are true and up-to-date.
    SOM INNOVATION BIOTECH, S.A. is responsible for the processing of my personal data to manage the newsletter service requested through the form, as well as to track the receipt of these through tracking technologies. The Privacy Policy tells me how I can exercise my rights of access, rectification, deletion, limitation, portability and opposition.